top of page

Ubrogepant vs. Triptans: Superior Relief for Migraines
A recent study published in Pain Management highlights the benefits of switching from triptans to ubrogepant for acute migraine treatment. The UNIVERS...

MigraineMind
Nov 20, 20251 min read
Beyond Headaches: Fatigue & Pain Affect Migraine Outcomes
A new study published in Pain Medicine explores how symptoms beyond headaches, such as fatigue and widespread non-cephalic pain, impact chronic migrai...

MigraineMind
Nov 20, 20251 min read
Migraine Sensory Insights: QST Reveals Pain Sensitivity Variances
A study published in the European Journal of Pain explored pain profiling in individuals with episodic and chronic migraine using quantitative sensory...

MigraineMind
Nov 20, 20251 min read
Daily Research Roundup: 11 New Migraine Studies
Today's migraine research brings 11 important studies covering breakthrough treatments, new insights, and innovative approaches to migraine management...

MigraineMind
Nov 20, 20251 min read
Migraine Burden Rising: Trends in China and Globally
A recent study published in Frontiers in Neurology has analyzed the trends in migraine burden in China and globally from 1990 to 2021, with projection...

MigraineMind
Nov 20, 20251 min read
Rimegepant: Effective Migraine Relief for Triptan-Intolerant Adults
In a new study published in Cephalalgia, researchers examined the efficacy and tolerability of rimegepant, a calcitonin gene-related peptide antagonis...

MigraineMind
Nov 20, 20251 min read
Rimegepant Reduces Migraine Days: New Hope for Sufferers
In a recent study published in the journal Cephalalgia, researchers explored the efficacy and tolerability of rimegepant for preventing episodic migra...

MigraineMind
Nov 20, 20251 min read
bottom of page